The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II
NCT02281838
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
142
Enrollment
OTHER
Sponsor class
Stopped
Slow enrolment after publication of the Interact III study
Conditions
Intracerebral Hemorrhage
Interventions
DRUG:
labetalol/hydralazine/enalapril
Sponsor
University of Alberta